Browsing Tag
Cardiac Diagnostics
4 posts
PET imaging firm Positron (OTC: POSC) secures $2m to scale operations and pursue FDA clearances
Positron Corporation raises $2M to scale its PET-CT imaging platform and pursue regulatory clearances. Find out what this means for cardiac diagnostics in 2026.
Why HeartBeam’s 510(k) appeal could reshape cardiac software approval timelines
HeartBeam outlines a dual-track regulatory strategy after FDA setback on ECG software. See how it plans to unlock clearance and stay on track for market entry.
Roche’s sixth-gen Troponin T test: Can it finally solve the accuracy problem in heart attack diagnosis?
Roche’s sixth-generation Troponin T test delivers new accuracy in heart attack diagnosis. Explore clinical results, adoption hurdles, and investor sentiment.
ABE Technology unveils CardioVision: A new era in AI-powered cardiac diagnostics
ABE Technology has introduced a groundbreaking innovation in cardiac care, CardioVision, an AI-powered cardiac imaging system that significantly…